Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_assertion description "[Therefore, the development of small molecule inhibitors of BCL2A1 may be a promising approach mainly to sensitize tumor cells for apoptosis and thus improve the efficiency of anti-cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_assertion evidence source_evidence_literature NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_assertion SIO_000772 22075983 NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_assertion wasDerivedFrom befree-20150227 NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_assertion wasGeneratedBy ECO_0000203 NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.
- befree-20150227 importedOn "2015-02-27" NP264198.RAFzjTD72u8YXOotA0afXndd18EgBUJkb-2bGa93pd5_I130_provenance.